Julia Lainster

The quiet confidence that comes with taking a daily pill to manage cholesterol or blood pressure often masks a dangerous misconception that its protective shield is impenetrable, regardless of what one eats. This belief, however, is being challenged by rigorous scientific inquiry, forcing a

The quiet aftermath of a traumatic event often conjures images of panicked awakenings and a constant state of high alert, yet for the vast majority of survivors, the most debilitating struggle is a silent, internal battle waged not against terror but against a crushing weight of sorrow and

The emergence of cell-cultured protein has sparked intense debate at the intersection of agricultural tradition and technological innovation, nowhere more so than in states with deep roots in the livestock industry. In South Dakota, a legislative effort to completely prohibit the sale of lab-grown

The ever-increasing complexity and volume of medical imaging have pushed modern radiology to a critical juncture, where the demand for expert interpretation often outstrips the available clinical capacity. The rise of artificial intelligence represents a significant advancement in the medical

The intricate landscape of the tumor microenvironment is increasingly recognized not as a simple collection of malignant cells, but as a complex ecosystem where cancer’s fate is dictated by a dynamic interplay with the body's own immune system. The targeting of specific immune cell subsets

Today, we sit down with Ivan Kairatov, a biopharma expert whose career has been dedicated to the intersection of technology, research, and development. As artificial intelligence begins to unlock the very code of life, it presents a dual-use dilemma of unprecedented scale—promising revolutionary

A promise of universal health care, once the gleaming centerpiece of Governor Gavin Newsom's progressive agenda for California, now appears tarnished by the harsh glare of fiscal austerity and national political ambition. The governor's controversial proposal to withhold state funding for health

With the recent unveiling of the Oceanic-Stroke trial data, the pharmaceutical world is buzzing about a new class of blood thinners that could revolutionize secondary stroke prevention. To help us understand the significance of these findings, we're joined by Ivan Kairatov, a biopharma expert with

A comprehensive global analysis involving 185 countries has delivered a profound message of hope and urgency, revealing that nearly four in ten cancer diagnoses are linked to preventable risk factors. This landmark study, a collaborative effort between the World Health Organization and the

The British monarchy, an institution historically defined by its stoic reserve, took an unprecedented step in 2024 when both King Charles and Catherine, the Princess of Wales, publicly disclosed their cancer diagnoses, shattering centuries of protocol that shrouded royal health in secrecy. This